Exogenous administered DL- sodium beta-hydroxybutyrate (beta-OHB) can cross the blood brain barrier.
Hussain
Khalid
K
Eaton
Simon
S
Clayton
Peter
P
D020155:3-Hydroxybutyric Acid / Q000493:pharmacokinetics*; D001812:Blood-Brain Barrier / Q000378:metabolism*; D001921:Brain / Q000378:metabolism*; D006801:Humans; D006946:Hyperinsulinism / Q000378:metabolism*; D007003:Hypoglycemia / Q000378:metabolism*; D007223:Infant
D020155:3-Hydroxybutyric Acid